Profound Medical Corp PROF

Primary Symbol: T.PRN

Healthcare Medical Devices

Profound Medical Corp. is a Canada-based commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue. It is commercializing TULSA-PRO, a technology that combines real-time magnetic resonance imaging (MRI), robotically driven transurethral ultrasound and closed-loop temperature feedback control. The TULSA procedure, performed using the TULSA-PRO system, has the potential of becoming a mainstream treatment modality across the entire prostate disease spectrum; ranging from low -, intermediate-, or high-risk prostate cancer; to hybrid patients suffering from both prostate cancer and benign prostatic hyperplasia (BPH); to men with BPH only; and also, to patients requiring salvage therapy for radio-recurrent localized prostate cancer. It is also commercializing Sonalleve, a therapeutic platform that is CE marked for the treatment of uterine fibroids and palliative pain treatment of bone metastases.

TSX:PRN - Post by User

Profound Medical Corp

<< Previous

Bullboard Posts

Next >>

Post by BuenaSuertaAtodon Feb 11, 2022 12:08pm

223 Views

Post# 34420618

Q4 & FY2021 Financial Results March 3, Conf call to follow

Fourth Quarter and Full Year 2021 Results Conference Call Details:

 Date: Thursday, March 3, 2022 Time: 4:30 p.m. ET Live Call: 1-833-710-1825 (Canada and the United States) 1-929-517-0404 (International) Replay: 1-404-537-3406 Conference ID: 9608479

The call will also be broadcast live and archived on the Company's website at www.profoundmedical.com under "Webcasts" in the Investors section.

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing